Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth 
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices 
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
 - EconoTimes)
NEW YORK, April 27, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BioAmber Inc. (NYSE:BIOA) who purchased shares pursuant and/or traceable to BioAmber’s secondary public offering on or about January 23, 2017; and/or (2) on the open market from January 23, 2017 through March 16, 2017. The action, which was filed in the United States District Court for the Northern District of California, alleges that the Company violated federal securities laws.
The complaint alleges that throughout the Class Period BioAmber made materially false and/or misleading statements and/or failed to disclose that: (1) a large customer of BioAmber that was expected to purchase $2.8 million of succinic acid in Q4 2016 experienced a technical problem in its manufacturing facility and postponed the order to 2017; and (2) as a result, defendants’ statements about BioAmber’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in BioAmber you have until May 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/bioamber-inc?wire=3.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
